Drawing for RIMSYS

USPTO serial 87830355

RIMSYS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DINALLO, KEVIN M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RIMSYS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sean P. Ritchie

Sean P. Ritchie STITES & HARBISON, PLLC401 Commerce StreetSuite 800NASHVILLE, TN 37219

Goods and services

ClassDescriptionStatusFirst use
035Regulatory submission management, namely, assisting others in preparing and filing applications for medical devices, in-vitro diagnostics, pharmaceuticals, biologics, dental, and other regulated products with governmental regulatory bodies; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing information and news in the field of business, namely, information and news on current events and on economic, legislative, and regulatory developments as it relates to and can impact businesses; and Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodiesACTIVE—
045Regulatory compliance consulting in the field of medical devices, in-vitro diagnostics, pharmaceuticals, biologics, dental, and other regulated industries; Tracking and monitoring regulatory requirements in the field of medical devices, in-vitro diagnostics, pharmaceuticals, biologics, dental, cannabis, and other regulated industries for regulatory compliance purposes; Computer software licensingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 17, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 17, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 20, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 16, 2020EX4GSOU EXTENSION 4 GRANTED—
Oct 16, 2020EXT4SOU EXTENSION 4 FILED—
Oct 16, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 18, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 16, 2020EX3GSOU EXTENSION 3 GRANTED—
Apr 16, 2020EXT3SOU EXTENSION 3 FILED—
Apr 16, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 29, 2019NOACCORRECTED NOA E-MAILED—
Oct 29, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 28, 2019DPCCDIVISIONAL PROCESSING COMPLETE—
Oct 28, 2019EX2GSOU EXTENSION 2 GRANTED—
Oct 16, 2019DRRRDIVISIONAL REQUEST RECEIVED—
Oct 16, 2019EXT2SOU EXTENSION 2 FILED—
Oct 16, 2019ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Oct 16, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 21, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 18, 2019EX1GSOU EXTENSION 1 GRANTED—
May 18, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 17, 2019NREVNOTICE OF REVIVAL - E-MAILED—
Apr 17, 2019TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Apr 17, 2019PETGPETITION TO REVIVE-GRANTED—
Apr 17, 2019PROATEAS PETITION TO REVIVE RECEIVED—
Apr 16, 2019EXT1SOU EXTENSION 1 FILED—
Oct 16, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 21, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 21, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 1, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 13, 2018ALIEASSIGNED TO LIE—
Jun 26, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 26, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jun 26, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 26, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 26, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 22, 2018DOCKASSIGNED TO EXAMINER—
Mar 19, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 15, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance